Drug Trial Radar · NCT04980482
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
43
Actual
Start
Oct 29, 2021
Primary completion
Mar 13, 2025
Study completion May 21, 2025
Sponsor
- Lead sponsor
- Arbutus Biopharma CorporationIndustry
- Sponsor type
- Industry
- First posted
- Jul 28, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, open label, multicenter Phase 2 study investigating the safety and antiviral activity of AB-729 in combination with ongoing NA therapy and short courses of Peg-IFNα-2a in subjects with CHB.
Conditions
- Chronic Hepatitis b
Interventions
AB-729Drug
subcutaneous injection
Peg-IFNα-2aDrug
subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Frequency and Severity of Treatment Emergent Adverse Events (TEAEs), Discontinuations Due to AEs and Lab Abnormalities After Dosing With AB-729 Plus Peg-IFNα-2aTime frame: Up to 124 weeks
Locations
17 sites in 7 countries. Site status is shown where the registry gives one.
Arizona Liver Health
Chandler, Arizona
Arizona Liver Health
Tucson, Arizona
Research and Education, Inc.
San Diego, California
University of Miami Miller School of Medicine
Miami, Florida
Henry Ford Health System
Detroit, Michigan
ID Care
Hillsborough, New Jersey
Nepean Hospital
Kingswood, New South Wales, Australia
St Vincent's Hospital Melbourne
Melbourne, Victoria, Australia
Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong, Hong Kong
Queen Mary Hospital
Hong Kong, Hong Kong
Arensia Exploratory Medicine Moldova
Chisinau, Moldova
Asan Medical Center
Seoul, South Korea
Pusan National University Hospital
Pusan, Republic of Korea, South Korea
Chia-Yi Christian Hospital
Chiayi City, Taiwan
Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Medical Center of Limited Liability Company Harmoniya Krasy
Kyiv, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.